Valeant Pharmaceuticals v. Actavis Laboratories FL., Inc
| SALIX PHARMACEUTICALS LTD., COSMO TECHNOLOGIES LIMITED and VALEANT PHARMACEUTICALS INTERNATIONAL |
| TEVA PHARMACEUTICAL INDUSTRIES LTD., ACTAVIS LABORATORIES FL., INC., TEVA PHARMACEUTICALS USA, INC. and ACTAVIS PHARMA, INC. |
| 20-1201 |
| December 4, 2019 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
| VALEANT PHARMACEUTICALS v. ACTAVIS LABORATORIES FL., INC |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 28, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 18 **TEXT ONLY** ORDER granting motion to extend time to file Appellants' opening brief [ # 17 ] filed by Appellants Valeant Pharmaceuticals International, Cosmo Technologies Limited and Salix Pharmaceuticals Ltd. The opening brief is due 03/04/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [666506] [TAM] [Entered: 01/28/2020 01:20 PM] |
| Filing 17 MOTION of Appellants Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd. and Cosmo Technologies Limited to extend the time to 03/04/2020 to file the Appellants' Opening Brief due 02/03/2020. [Consent: unopposed]. Service: 01/24/2020 by email. [665969] [20-1201] [Thomas Steindler] [Entered: 01/24/2020 04:39 PM] |
| Filing 16 Entry of appearance for Yite John Lu as of counsel for Appellant Cosmo Technologies Limited. Service: 12/18/2019 by email. [657680] [20-1201] [Yite Lu] [Entered: 12/18/2019 06:24 PM] |
| Filing 15 Docketing Statement for the Appellant Cosmo Technologies Limited. Service: 12/18/2019 by email. [657679] [20-1201] [Gary Frischling] [Entered: 12/18/2019 06:19 PM] |
| Filing 14 Certificate of Interest for Appellant Cosmo Technologies Limited. Service: 12/18/2019 by email. [657677] [20-1201] [Gary Frischling] [Entered: 12/18/2019 06:18 PM] |
| Filing 13 Entry of appearance for Gary Frischling as principal counsel for Appellant Cosmo Technologies Limited. Service: 12/18/2019 by email. [657675] [20-1201] [Gary Frischling] [Entered: 12/18/2019 06:16 PM] |
| Filing 12 Entry of appearance for Christopher M. Bruno as of counsel for Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 12/18/2019 by email. [657628] [20-1201] [Thomas Steindler] [Entered: 12/18/2019 04:09 PM] |
| Filing 11 Entry of appearance for Paul M. Schoenhard as of counsel for Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 12/18/2019 by email. [657626] [20-1201] [Thomas Steindler] [Entered: 12/18/2019 04:08 PM] |
| Filing 10 Docketing Statement for the Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 12/18/2019 by email. [657624] [20-1201] [Thomas Steindler] [Entered: 12/18/2019 04:06 PM] |
| Filing 9 Certificate of Interest for Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 12/18/2019 by email. [657623] [20-1201] [Thomas Steindler] [Entered: 12/18/2019 04:05 PM] |
| Filing 8 Entry of appearance for Thomas P. Steindler as principal counsel for Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 12/18/2019 by email. [657618] [20-1201] [Thomas Steindler] [Entered: 12/18/2019 04:03 PM] |
| Filing 7 Entry of appearance for Joshua James Bone as of counsel for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657528] [20-1201] [Joshua Bone] [Entered: 12/18/2019 12:56 PM] |
| Filing 6 Entry of appearance for John T. Bennett as of counsel for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657524] [20-1201] [John Bennett] [Entered: 12/18/2019 12:54 PM] |
| Filing 5 Entry of appearance for Elizabeth J. Holland as of counsel for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657522] [20-1201] [Elizabeth Holland] [Entered: 12/18/2019 12:52 PM] |
| Filing 4 Certificate of Interest for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657519] [20-1201] [William Jay] [Entered: 12/18/2019 12:49 PM] |
| Filing 3 Docketing Statement for the Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657518] [20-1201] [William Jay] [Entered: 12/18/2019 12:48 PM] |
| Filing 2 Entry of appearance for William M. Jay as principal counsel for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657488] [20-1201] [William Jay] [Entered: 12/18/2019 12:06 PM] |
| Filing 1 Appeal docketed. Received: 11/22/2019. [653858] Entry of Appearance due 12/18/2019. Certificate of Interest is due on 12/18/2019. Docketing Statement due 12/18/2019. Appellant's brief is due 02/03/2020. [TAM] [Entered: 12/04/2019 09:21 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
